<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2001</study_start_year><condition>Secondary</condition><condition>Colorectal Neoplasms</condition><condition>Drug Therapy, Combination</condition><disease>Secondary</disease><disease>Colorectal Neoplasms</disease><disease>Drug Therapy, Combination</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2042450</full_dataset_link><location>South Korea</location><study_start_month>11</study_start_month><keyword>Irinotecan</keyword><keyword>Capecitabine</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Study of Irinotecan &amp; Capecitabine in Metastatic Colorectal Cancer</name><description>This study is to evaluate the efficacy and safety of combination chemotherapy with irinotecan and capecitabine in previously untreated metastatic colorectal cancer.</description><dates><creation>2001-11-15</creation></dates><accession>2042450</accession><cross_references><ClinicalTrials___gov>NCT00506168</ClinicalTrials___gov></cross_references></HashMap>